The present invention relates to a delivery device for and method of delivering a metered volume of substance, in particular a delivery device for delivering a metered volume of a liquid substance to a nasal cavity of a subject.
Very many delivery devices exist for the delivery of liquid substances, which typically comprise a manually-actuated pump for the delivery of a liquid substance as an aerosol spray.
Whilst these delivery devices have found extensive application, the present inventors have recognized the need for a delivery device which utilizes the exhalation breath of a user as the driving force to deliver a metered dose of a liquid substance.
In one aspect the present invention provides a delivery device for delivering a metered amount of substance in response to exhalation by a user, the delivery device comprising: a mouthpiece through which the user in use exhales; an outlet from which substance is delivered; and a dispensing unit which is operable to dispense a metered amount of substance through the outlet in response to exhalation by the user through the mouthpiece, wherein the dispensing unit comprises a body member which includes a cavity for containing a metered amount of substance, an outlet nozzle which is fluidly connected to the cavity from which substance is in use delivered, and a dispensing member which is movably disposed in the cavity and configured to be driven through the cavity by a driving pressure created by exhalation of the user, such as to cause substance to be delivered from the outlet nozzle.
In one embodiment the cavity is an elongate cavity.
In one embodiment the cavity has a cylindrical section and the dispensing member comprises a ball which is moved along the cavity by the driving pressure created by exhalation of the user.
In one embodiment the ball sealingly engages with an inner peripheral wall of the cavity.
In one embodiment the cavity and the dispensing member are configured to provide for movement of the dispensing member at a driving pressure of less than about 5 kPa, and preferably less than about 3 kPa.
In one embodiment the outlet nozzle provides for an aerosol spray.
In one embodiment the outlet nozzle provides for a substantially rectilinear flow for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from exit of the outlet nozzle.
In another embodiment the outlet nozzle provides for a jet.
In one embodiment the delivery device further comprises: a pressure regulator which is fluidly connected to the dispensing unit, such as to provide for application of a predeterminable driving pressure to the dispensing member.
In one embodiment the mouthpiece and the outlet are fluidly connected, such as to provide for an air flow through the outlet on exhalation by the user through the mouthpiece.
In one embodiment the delivery device further comprises: a housing in which the dispensing unit is disposed and to which the mouthpiece and the nosepiece are fluidly connected, such as to define a fluid communication path therebetween.
In one embodiment the delivery device further comprises: a baffle member which is disposed in the fluid communication path.
In one embodiment the baffle member includes a first, driving air pressure channel which is fluidly connected to the dispensing unit and at which the driving pressure is created on exhalation by the user to actuate the dispensing unit, and at least one second, entraining air flow channel through which an entraining air flow is delivered for entraining substance as delivered by the dispensing unit.
In one embodiment the baffle member includes a plurality of entraining air flow channels.
In one embodiment the housing includes an inlet chamber upstream of the baffle member which flares outwardly from the mouthpiece.
In one embodiment the housing includes an outlet chamber downstream of the baffle member.
In one embodiment the outlet chamber surrounds the dispensing unit.
In one embodiment the outlet includes a flow restrictor for providing a flow restriction thereat.
In one embodiment the flow restrictor tapers inwardly in a flow direction from the mouthpiece to the nosepiece.
In one embodiment the flow restrictor has a frusto-conical section.
In one embodiment the delivery device further comprises: a flow regulator which is disposed at the outlet nozzle of the dispensing unit.
In one embodiment the flow regulator includes a plurality of flow apertures which are located on an annulus surrounding the outlet nozzle.
In one embodiment the delivery device is configured to deliver a liquid.
In one embodiment the outlet is a nosepiece and the delivery device is a nasal delivery device for delivering substance to a nasal airway of a subject.
A preferred embodiment of the present invention will now be described hereinbelow by way of example only with reference to the accompanying drawings, in which:
The delivery device comprises a first, inlet housing part 3 which defines a mouthpiece 5 at one, inlet end thereof and an inlet chamber 7 which is in fluid communication with the mouthpiece 5 and the other, outlet end of which is open, such that exhalation by a user into the mouthpiece 5 delivers an air flow into the inlet chamber 7 and to the open, outlet end thereof.
In this embodiment the mouthpiece 5 comprises a tubular section which is gripped in the lips of the user.
In this embodiment the inlet chamber 7 flares outwardly from the mouthpiece 5, here having a frusto-conical section.
The delivery device further comprises a baffle member 11 which sealingly engages the open, outlet end of the inlet chamber 7, such as to direct the air flow as delivered through the inlet chamber 7.
The baffle member 11 includes a first, driving air pressure channel 21 at which a driving pressure is created, which acts to drive a liquid dispensing unit 35, as will be described in more detail hereinbelow, and at least one, in this embodiment a plurality of second, entraining air flow channels 23 through which an entraining air flow F is delivered.
In this embodiment the first, driving air pressure channel 21 is located on the longitudinal axis of the inlet chamber 7. In this embodiment the driving air pressure channel 21 has a circular section, here having a diameter of at or less than about 6 mm.
In this embodiment the entraining air flow channels 23 are located such as to be in fluid communication with the periphery of the open, outlet end of the inlet chamber 7. In this embodiment the baffle member 11 includes four entraining air flow channels 23 which are disposed uniformly on an annulus about the longitudinal axis of the inlet housing part 3, and each have a circular section, here having a diameter of at or less than about 4 mm.
In this embodiment the baffle member 11 comprises first and second baffle elements 25, 27, here plates which are disposed in juxtaposed relation.
The delivery device further comprises a pressure regulator 29 which includes an aperture 31 which is fluidly connected to the driving air pressure channel 21 in the baffle member 11, in this embodiment at the downstream end thereof, such as to provide for the generation of a predetermined pressure thereat. In this embodiment the aperture 31 has a circular section, here having a diameter of at or less than about 4 mm.
The delivery device further comprises a liquid dispensing unit 35 which is fluidly connected to the pressure regulator 29 such as to be actuated by the driving air pressure P as generated on exhalation by the user through the mouthpiece 5.
The liquid dispensing unit 35 comprises a body member 37, in this embodiment a tubular member, here of cylindrical section, which defines an elongate cavity 39 which contains a metered dose of a liquid L, a dispensing member 41 which is movably disposed in the cavity 39, such as to be moved along the cavity 39 under the action of the driving air pressure P and thereby dispense the liquid L from the cavity 39, and an outlet nozzle 43 which is configured to provide for dispensing of the liquid L at a predetermined rate.
In this embodiment the cavity 39 has a volume of about 1 ml. In another embodiment the cavity 39 could have a volume of or less than about 200 μl.
In this embodiment the dispensing member 41 is initially disposed at one end of the cavity 39 adjacent the flow regulator 29 and is moved to the other end of the cavity 39 under the action of the driving air pressure, with the liquid L as contained in the cavity 39 being progressively dispensed as the dispensing member 41 is moved along the cavity 39.
In this embodiment the dispensing member 41 and the cavity 39 of the liquid dispensing unit 35 are configured to provide for movement with a driving air pressure P at or less than about 5 kPa and preferably at or less than about 3 kPa.
In this embodiment the dispensing member 41 is a ball which sealingly engages the peripheral wall of the cavity 39.
The outlet nozzle 43 includes an outlet orifice 45 which is shaped and dimensioned, in this embodiment having a circular section, to provide the dispensed liquid with a predetermined profile. In this embodiment the outlet orifice 45 is configured to dispense the liquid L such that the flow of liquid L remains substantially rectilinear for a distance of at least about 15 mm, preferably at least about 20 mm, more preferably at least about 25 mm and yet more preferably at least about 30 mm from the exit of the outlet orifice 45 and thereafter provide a dispersed aerosol spray, as illustrated in
In preferred embodiments the outlet orifice 45 has a diameter of at or less than about 3 mm, preferably at or less than about 2 mm, and more preferably at or less than about 1 mm.
In this embodiment the outlet nozzle 43 includes a frangible membrane which normally encloses the outlet orifice 45 thereof such as to contain the liquid L and is ruptured on the application of the driving air pressure P to the liquid L.
The delivery device further comprises a second, outlet housing part 51 which defines a nosepiece 53 at one, outlet end thereof and an outlet chamber 57, in this embodiment an annular chamber surrounding the body member 37 of the liquid dispensing unit 35, which is in fluid communication with the entraining air flow channels 23 in the baffle member 11 and opens to an outlet end thereof, such that exhalation by a user into the mouthpiece 5 delivers an entraining air flow F into the outlet chamber 57 and to the open, outlet end thereof.
The delivery device further comprises a flow regulator 61 which encloses the annular outlet chamber 57 at the outlet end of the body member 37 of the liquid dispensing unit 35.
In this embodiment the flow regulator 61 includes a plurality of flow apertures 63, in this embodiment sixteen apertures, which are located on an annulus surrounding the body member 37 of the liquid dispensing unit 35, such as to provide for the delivery of a substantially annular entraining air flow F which entrains the liquid L as dispensed from the liquid-containing cavity 39 of the liquid dispensing unit 35.
In this embodiment the flow regulator 61 is configured to provide for a flow rate of at least about 20 l/min, more preferably at least about 30 l/min, still more preferably at least about 40 l/min and yet more preferably at least about 50 l/min.
In this embodiment the flow apertures 63 have a circular section, here of a diameter of at or less than about 1 mm.
Operation of the above-described delivery device will now be described hereinbelow with reference to
A user first inserts the nosepiece 53 into one of his/her nostrils and then grips the mouthpiece 5 in his/her lips. It should be understood that, for the sake of ease of illustration, the delivery device has been illustrated in an elongate configuration where the nosepiece 53 and the mouthpiece 5 are located on a common axis. In practice, the nosepiece 53 and the mouthpiece 5 would be inclined relative to one another, such as to facilitate fitting of the nosepiece 53 and the mouthpiece 5 in respective ones of a nostril and the lips.
The user then exhales through the mouthpiece 5, which is in fluid communication with the inlet chamber 7.
This exhalation acts to generate a driving air pressure P at the driving air pressure channel 21 in the baffle member 11 and an entraining air flow F through the entraining air flow channels 23 in the baffle member 11, which entraining air flow F continues through the outlet chamber 57 and the flow apertures 63 in the entraining air flow regulator 61, which define a substantially annular entraining air flow F which surrounds the outlet end of the liquid dispensing unit 35.
The driving air pressure P as created at the driving air pressure channel 21 simultaneously acts on the dispensing member 41, which is located in the cavity 39 of the liquid dispensing unit 35, such as to move the same along the cavity 39 and dispense the liquid L as contained therein from the outlet end thereof into the entraining air flow F, which surrounds the same, thereby providing for delivery of the liquid L, in this embodiment into the nasal cavity of the user.
In this embodiment the delivery device, in providing for the delivery of the liquid L in an entraining air flow F, advantageously provides for delivery into and through the nasal airway in the manner as described in the applicant's earlier WO-A-2000/051672, the content of which is herein incorporated by reference.
Finally, it will be understood that the present invention has been described in its preferred embodiment and can be modified in many different ways without departing from the scope of the invention as defined by the appended claims.
In one modification, as illustrated in
Number | Date | Country | Kind |
---|---|---|---|
0623731.7 | Nov 2006 | GB | national |
This application is a continuation application of U.S. application Ser. No. 15/133,356, filed on Apr. 20, 2016, which is a continuation application of U.S. application Ser. No. 14/171,554, filed on Feb. 3, 2014, now abandoned, which is a continuation application of U.S. application Ser. No. 12/516,401, filed on Jul. 12, 2010, now abandoned, which is a U.S. national phase application of International Application No. PCT/IB2007/004353, filed on Nov. 28, 2007, which claims priority to GB Application No. 0623731.7, filed on Nov. 28, 2006. The disclosure of each of the above applications is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
605436 | Kellogg | Jun 1898 | A |
642748 | Manners | Feb 1900 | A |
658436 | Groth | Sep 1900 | A |
746749 | Seidel | Dec 1903 | A |
794641 | Ramey | Jul 1905 | A |
902832 | Philbrook | Nov 1908 | A |
4820306 | Gorman et al. | Apr 1989 | A |
5797392 | Keldmann et al. | Aug 1998 | A |
6648848 | Keldmann et al. | Nov 2003 | B1 |
6715485 | Djupesland | Apr 2004 | B1 |
D530815 | Murphy et al. | Oct 2006 | S |
7347201 | Djupesland | Mar 2008 | B2 |
7377901 | Djupesland et al. | May 2008 | B2 |
7481218 | Djupesland | Jan 2009 | B2 |
7543581 | Djupesland | Jun 2009 | B2 |
7740014 | Djupesland | Jun 2010 | B2 |
7784460 | Djupesland et al. | Aug 2010 | B2 |
7841337 | Djupesland | Nov 2010 | B2 |
7854227 | Djupesland | Dec 2010 | B2 |
7934503 | Djupesland et al. | May 2011 | B2 |
7975690 | Djupesland | Jul 2011 | B2 |
8047202 | Djupesland | Nov 2011 | B2 |
8146589 | Djupesland | Apr 2012 | B2 |
8171929 | Djupesland et al. | May 2012 | B2 |
8327844 | Djupesland | Dec 2012 | B2 |
8511303 | Djupesland | Aug 2013 | B2 |
8522778 | Djupesland | Sep 2013 | B2 |
8550073 | Djupesland | Oct 2013 | B2 |
8555877 | Djupesland | Oct 2013 | B2 |
8555878 | Djupesland | Oct 2013 | B2 |
8590530 | Djupesland et al. | Nov 2013 | B2 |
8596278 | Djupesland | Dec 2013 | B2 |
8800555 | Djupesland | Aug 2014 | B2 |
8875704 | Djupesland et al. | Nov 2014 | B2 |
8899229 | Djupesland et al. | Dec 2014 | B2 |
8910629 | Djupesland et al. | Dec 2014 | B2 |
D723156 | Djupesland et al. | Feb 2015 | S |
D725769 | Djupesland et al. | Mar 2015 | S |
8978647 | Djupesland et al. | Mar 2015 | B2 |
9010325 | Djupesland et al. | Apr 2015 | B2 |
9038630 | Djupesland et al. | May 2015 | B2 |
9067034 | Djupesland et al. | Jun 2015 | B2 |
9072857 | Djupesland | Jul 2015 | B2 |
9108015 | Djupesland | Aug 2015 | B2 |
9119932 | Djupesland | Sep 2015 | B2 |
9132249 | Djupesland | Sep 2015 | B2 |
9144652 | Djupesland et al. | Sep 2015 | B2 |
9168341 | Djupesland | Oct 2015 | B2 |
9205208 | Djupesland | Dec 2015 | B2 |
9205209 | Djupesland | Dec 2015 | B2 |
9272104 | Djupesland | Mar 2016 | B2 |
D759805 | Djupesland | Jun 2016 | S |
D761951 | Djupesland | Jul 2016 | S |
9452272 | Djupesland et al. | Sep 2016 | B2 |
9468727 | Djupesland | Oct 2016 | B2 |
D773644 | Djupesland | Dec 2016 | S |
9522243 | Djupesland | Dec 2016 | B2 |
9566402 | Djupesland | Feb 2017 | B2 |
9649456 | Djupesland et al. | May 2017 | B2 |
D809128 | Djupesland | Jan 2018 | S |
9949923 | Djupesland | Apr 2018 | B2 |
20040024330 | Djupesland et al. | Feb 2004 | A1 |
20040112378 | Djupesland | Jun 2004 | A1 |
20040112379 | Djupesland | Jun 2004 | A1 |
20040112380 | Djupesland | Jun 2004 | A1 |
20040149289 | Djupesland | Aug 2004 | A1 |
20040182388 | Djupesland | Sep 2004 | A1 |
20050028812 | Djupesland | Feb 2005 | A1 |
20050072430 | Djupesland | Apr 2005 | A1 |
20050235992 | Djupesland | Oct 2005 | A1 |
20060096589 | Djupesland | May 2006 | A1 |
20060107957 | Djupesland | May 2006 | A1 |
20060169278 | Djupesland et al. | Aug 2006 | A1 |
20060219240 | Djupesland | Oct 2006 | A1 |
20060219241 | Djupesland | Oct 2006 | A1 |
20060225732 | Djupesland | Oct 2006 | A1 |
20060231094 | Djupesland | Oct 2006 | A1 |
20070039614 | Djupesland | Feb 2007 | A1 |
20070125371 | Djupesland | Jun 2007 | A1 |
20070186927 | Djupesland et al. | Aug 2007 | A1 |
20080161771 | Djupesland | Jul 2008 | A1 |
20080163874 | Djupesland | Jul 2008 | A1 |
20080221471 | Djupesland et al. | Sep 2008 | A1 |
20080223363 | Djupesland | Sep 2008 | A1 |
20080289629 | Djupesland et al. | Nov 2008 | A1 |
20090101146 | Djupesland | Apr 2009 | A1 |
20090293873 | Djupesland et al. | Dec 2009 | A1 |
20090304802 | Djupesland et al. | Dec 2009 | A1 |
20090314293 | Djupesland | Dec 2009 | A1 |
20090320832 | Djupesland | Dec 2009 | A1 |
20100035805 | Hafner | Feb 2010 | A1 |
20100051022 | Djupesland et al. | Mar 2010 | A1 |
20100057047 | Djupesland et al. | Mar 2010 | A1 |
20100199984 | Williams et al. | Aug 2010 | A1 |
20100242959 | Djupesland et al. | Sep 2010 | A1 |
20100282246 | Djupesland et al. | Nov 2010 | A1 |
20100288275 | Djupesland et al. | Nov 2010 | A1 |
20100300439 | Djupesland et al. | Dec 2010 | A1 |
20110023869 | Djupesland | Feb 2011 | A1 |
20110053827 | Hafner | Mar 2011 | A1 |
20110088690 | Djupesland et al. | Apr 2011 | A1 |
20110088691 | Djupesland | Apr 2011 | A1 |
20110114087 | Djupesland et al. | May 2011 | A1 |
20110120456 | Immel | May 2011 | A1 |
20110126830 | Djupesland et al. | Jun 2011 | A1 |
20110259329 | Djupesland et al. | Oct 2011 | A1 |
20110318345 | Djupesland | Dec 2011 | A1 |
20120000459 | Djupesland | Jan 2012 | A1 |
20120006323 | Djupesland | Jan 2012 | A1 |
20120073571 | Djupesland | Mar 2012 | A1 |
20120090608 | Djupesland et al. | Apr 2012 | A1 |
20120260915 | Djupesland | Oct 2012 | A1 |
20130098362 | Djupesland et al. | Apr 2013 | A1 |
20130125889 | Djupesland et al. | May 2013 | A1 |
20130327320 | Djupesland | Dec 2013 | A1 |
20140018295 | Djupesland | Jan 2014 | A1 |
20140041660 | Djupesland et al. | Feb 2014 | A1 |
20140060536 | Djupesland | Mar 2014 | A1 |
20140073562 | Djupesland | Mar 2014 | A1 |
20140144442 | Djupesland et al. | May 2014 | A1 |
20140144443 | Djupesland et al. | May 2014 | A1 |
20140166008 | Djupesland | Jun 2014 | A1 |
20140202456 | Djupesland | Jul 2014 | A1 |
20140246022 | Djupesland et al. | Sep 2014 | A1 |
20150007811 | Djupesland et al. | Jan 2015 | A1 |
20150013670 | Djupesland et al. | Jan 2015 | A1 |
20150013677 | Djupesland et al. | Jan 2015 | A1 |
20150053201 | Djupesland et al. | Feb 2015 | A1 |
20150090259 | Djupesland et al. | Apr 2015 | A1 |
20150101605 | Djupesland et al. | Apr 2015 | A1 |
20150144129 | Djupesland et al. | May 2015 | A1 |
20150165139 | Hafner | Jun 2015 | A1 |
20150182709 | Djupesland | Jul 2015 | A1 |
20150246194 | Djupesland et al. | Sep 2015 | A1 |
20150367090 | Djupesland et al. | Dec 2015 | A1 |
20150367091 | Djupesland et al. | Dec 2015 | A1 |
20160001022 | Djupesland et al. | Jan 2016 | A1 |
20160045687 | Djupesland | Feb 2016 | A1 |
20160051778 | Djupesland et al. | Feb 2016 | A1 |
20160074603 | Djupesland et al. | Mar 2016 | A1 |
20160082206 | Djupesland et al. | Mar 2016 | A1 |
20160082207 | Djupesland et al. | Mar 2016 | A1 |
20160095989 | Djupesland | Apr 2016 | A1 |
20160095993 | Djupesland | Apr 2016 | A1 |
20160101249 | Djupesland | Apr 2016 | A1 |
20160166788 | Djupesland et al. | Jun 2016 | A1 |
20160184537 | Djupesland | Jun 2016 | A1 |
20160193435 | Djupesland | Jul 2016 | A1 |
20160250408 | Djupesland | Sep 2016 | A1 |
20160263334 | Djupesland | Sep 2016 | A1 |
20160279357 | Djupesland | Sep 2016 | A1 |
20160310683 | Djupesland et al. | Oct 2016 | A1 |
20160331916 | Djupesland et al. | Nov 2016 | A1 |
20160367771 | Djupesland | Dec 2016 | A1 |
20160367772 | Djupesland | Dec 2016 | A1 |
20160367774 | Djupesland et al. | Dec 2016 | A1 |
20170043108 | Djupesland et al. | Feb 2017 | A1 |
20170151397 | Djupesland | Jun 2017 | A1 |
20170203061 | Djupesland et al. | Jul 2017 | A1 |
20170216540 | Djupesland | Aug 2017 | A1 |
20170274164 | Djupesland et al. | Sep 2017 | A1 |
20170333649 | Djupesland | Nov 2017 | A1 |
Number | Date | Country |
---|---|---|
2 381 460 | May 2003 | GB |
2 404 867 | Feb 2005 | GB |
2 418 147 | Mar 2006 | GB |
WO 9622802 | Aug 1996 | WO |
WO 9853869 | Dec 1998 | WO |
WO 0051672 | Sep 2000 | WO |
WO 0197689 | Dec 2001 | WO |
WO 02068029 | Sep 2002 | WO |
WO 02068030 | Sep 2002 | WO |
WO 02068031 | Sep 2002 | WO |
WO 02068032 | Sep 2002 | WO |
WO 03000310 | Jan 2003 | WO |
WO 03020350 | Mar 2003 | WO |
WO 03082393 | Oct 2003 | WO |
WO 03084591 | Oct 2003 | WO |
WO 03090812 | Nov 2003 | WO |
WO 2004004814 | Jan 2004 | WO |
WO 2004004922 | Jan 2004 | WO |
WO 2004060433 | Jul 2004 | WO |
WO 2004103447 | Dec 2004 | WO |
WO 2005016423 | Feb 2005 | WO |
WO 2005021059 | Mar 2005 | WO |
WO 2006030210 | Mar 2006 | WO |
WO 2006090149 | Aug 2006 | WO |
WO 2007083073 | Jul 2007 | WO |
WO 2007093784 | Aug 2007 | WO |
WO 2007093791 | Aug 2007 | WO |
WO 2007099361 | Sep 2007 | WO |
WO 2007102089 | Sep 2007 | WO |
WO 2007107887 | Sep 2007 | WO |
WO 2007125318 | Nov 2007 | WO |
WO 2007141541 | Dec 2007 | WO |
WO 2008012531 | Jan 2008 | WO |
WO 2008065403 | Jun 2008 | WO |
WO 2008081326 | Jul 2008 | WO |
WO 2008081327 | Jul 2008 | WO |
WO 2008122791 | Oct 2008 | WO |
WO 2008122795 | Oct 2008 | WO |
WO 2009044172 | Apr 2009 | WO |
WO 2010029441 | Mar 2010 | WO |
WO 2012035427 | Mar 2012 | WO |
WO 2012123819 | Sep 2012 | WO |
WO 2013124491 | Aug 2013 | WO |
WO 2013124492 | Aug 2013 | WO |
WO 2013124493 | Aug 2013 | WO |
WO 2014155192 | Oct 2014 | WO |
Entry |
---|
Cindy H. Dubin, Nothing to Sneeze At, Pharmaceutical Formulation & Quality Magazine (Jan. 29, 2003). |
Per Gisle Djupesland, Nasal Delivery of Vaccines, EPC (Jan. 29, 2003). |
Per Gisle Djupesland, Who Nose How Far Nasal Delivery Can Go?, EPC (Oct. 7, 2003). |
Per Gisle Djupesland, Bi-directional Nasal Drug Delivery, Innovations in Pharmaceutical Technology (Jul. 10, 2004). |
P.G. Djupesland, Bi-Directional Nasal Delivery of Aerosols Can Prevent Lung Deposition, Journal of Aerosol Medicine (Sep. 2004). |
Bi-Directional Nasal Device Delivers Drug on Exhalation, Pharmaceutical Technology (Sep. 10, 2004). |
Ola Dale et al., Intranasal Midazolam: A Comparison of Two Delivery Devices in Human Volunteers, Journal of Pharmacy and Pharmacology (Oct. 2004). |
G. Furness, Nasal Drug Delivery: Rapid Onset Via a Convenient Route, ONdrugDelivery Ltd. (2005). |
M. Kleven, Using Computational Fluid Dynamics (CFD) to Improve the Bi-Directional Nasal Drug Delivery Concept, Trans IChemE Part C. (Jun. 2005). |
Per Gisle Djupesland, Breath-Actuated Bi-Directional Delivery Sets the Nasal Market on a New Course, ONdrugDelivery (Oct. 10, 2005). |
Hilde Bakke et al., Oral Spray Immunization May be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies But Not Nasal Mucosal or Cellular Immunity, Scan J. of Immunol. (Mar. 2006). |
P.G. Djupesland et al., Breath Actuated Nasal Device Improves Delivery to Target Sites Beyond the Nasal Valve, The Laryngoscope (Mar. 2006). |
R. Luthringer et al., Rapid Absorption of Sumatriptan Powder and Effects on Glyceryl tinitrate Model of Headache Following Intranasal Delivery Using a Novel Bi-Directional Device, Journal of Pharmacy and Pharmacology (Jan. 2009). |
A. Skretting et al., A New Method for Scintigraphic Quantification of Deposition and Clearance in Anatomical Regions of the Human Nose, Nuclear Medicine Communications (Aug. 2009). |
Vlckovia et al., Effective Treatment of Mild-to-Moderate Nasal Polyposis with Fluticasone Delivered by a Novel Device, Rhinology (Oct. 22, 2009). |
Per Gisle Djupesland et al., Impact of Baseline Nasal Polyp Size and Previous Surgery on Efficacy of Fluticasone Delivered With a Novel Device: A Subgroup Analysis, Am. J. Rhinology Allergy (2010). |
P.G. Djupesland et al., Intranasal Sumatriptan Powder Delivered by a Novel Breath Actuated Bi-Directional Device for the Acute Treatment of Migraine: A Randomised Placebo-Controlled Study, Cephalalgia (Mar. 17, 2010). |
F.S. Hansen et al., Preliminary Efficacy of Fluticasone Delivered by a Novel Device in Recalcitrant Chronic Rhinosinusitis, Rhinology (Jun. 26, 2010). |
Per Gisle Djupesland, Nasal Drug Delivery Devices: Characteristics and Performance in Clinical Perspective—A Review, Drug. Deliv. and Transl. Res. (Oct. 18, 2012). |
Per Gisle Djupesland, Nasal Deposition and Clearance in Man: Comparison of a Bidirectional Powder Device and a Traditional Liquid Spray Pump, Journal of Aerosol Medicine and Pulmonary Drug Delivery (Nov. 2012). |
Stewart J. Tepper, Clinical Implications for Breath-Powered Powder Sumatriptan Intranasal Treatment, Headache, The American Headache Society (Apr. 29, 2013). |
Mohammad Obaidi et al., Improved Pharmacokinetics of Sumatriptan With Breath Powered Nasal Delivery of Sumatriptan Powder, Headache, The American Headache Society (May 24, 2013). |
Per Gisle Djupesland, Breath Powdered Nasal Delivery: A New Route to Rapid Headache Relief, Headache, The American Headache Society (Jun. 4, 2013). |
Per Gisle Djupesland et al., The Nasal Approach to Delivering Treatment for Brain Diseases: An Anatomic, Physiologic, and Delivery Technology Overview, Therapeutic Delivery (2014). |
R.K. Cady et al., A Randomized Double-Blind, Placebo Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The Target Study), Headache (Sep. 8, 2014). |
S.J. Tepper et al., AVP-825 Breath-Powdered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs. 100 mg Oral Sumatripta in the Acute Treatment of Migraines (The Compass Study): A Comparative Randomized Clinical Trial Across Multiple Attacks, Headache: The Journal of Head and Face Pain (Mar. 29, 2015). |
D. S. Quintana et al., Low-dose Oxytocin Delivered Intranasally with Breath Powdered Device Affects Social-Cognitive Behavior: A Randomized Four-Way Crossover Trial with Nasal Cavity Dimension Assessment, Transl Psychiatry (Jul. 14, 2015). |
R. Mahmoud, Breathe Out, Innovations in Phar, Tech. (Dec. 10, 2015). |
Number | Date | Country | |
---|---|---|---|
20190099565 A1 | Apr 2019 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15133356 | Apr 2016 | US |
Child | 15936251 | US | |
Parent | 14171554 | Feb 2014 | US |
Child | 15133356 | US | |
Parent | 12516401 | US | |
Child | 14171554 | US |